Bristol-Myers Squibb buy UBS Group AG
Start price
07.01.26
/
50%
€47.50
Target price
07.01.27
€55.55
Performance (%)
3.79%
Price
27.04.26
€49.30
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 3.79%. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -1.715% | -1.715% |
| iShares Core DAX® | -1.424% | 8.918% |
| iShares Nasdaq 100 | 3.274% | 16.275% |
| iShares Nikkei 225® | 1.745% | 16.239% |
| iShares S&P 500 | 1.447% | 10.913% |
Comments by UBS_Group_AG for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat